特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
966292

細胞株開発の世界市場:COVID-19の影響とタイプ別、製品別、用途別、地域別の分析

Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; By Product ; Application ; and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 181 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
細胞株開発の世界市場:COVID-19の影響とタイプ別、製品別、用途別、地域別の分析
出版日: 2020年09月16日
発行: The Insight Partners
ページ情報: 英文 181 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞株開発の市場規模は、2019年の41億6,042万米ドルから2027年には112億1,987万米ドルに拡大すると予測されており、2020年から2027年までのCAGRは13.3%になる見通しです。

当レポートは、世界の細胞株開発市場を調査したもので、市場の情勢と力学、タイプ別、製品別、用途別、地域別の分析と予測、新型コロナウイルス感染症(COVID-19)の影響、業界の情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 主な調査結果

第3章 調査手法

第4章 市場の情勢

  • 概要
  • PEST分析
  • 専門家の見解

第5章 市場の主な力学

  • 主な成長促進要因
  • 主な成長阻害要因
  • 重要な機会
  • 今後の動向
  • 影響分析

第6章 世界市場の分析

  • 世界市場の予測と分析
  • 地域市場の予測と分析
  • 主要企業の市場でのポジショニング

第7章 タイプ別の収益と予測

  • 概要
  • 初代細胞株
  • ハイブリドーマ
  • 連続細胞株
  • 組換え細胞株

第8章 製品別の分析と予測

  • 概要
  • 装置
  • 培地と試薬

第9章 用途別の分析と予測

  • 概要
  • 創薬
  • バイオプロダクション
  • ティッシュエンジニアリング

第10章 地域別の収益と予測

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第11章 COVID-19パンデミックが市場に与える影響

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第12章 業界の情勢

  • 概要
  • 成長戦略
  • 有機的発展
  • 無機的発展

第13章 主要企業のプロファイル

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • SELEXIS
  • BioFactura, Inc.
  • WuXi AppTec
  • LakePharma, Inc.
  • General Electric
  • Lonza
  • Corning Incorporated

第14章 付録

  • The Insight Partners について
  • 用語集
図表

List Of Tables

  • Table 1. North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 2. North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 3. North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 4. US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 5. US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 6. US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 7. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 8. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 9. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 10. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 11. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 12. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 13. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 14. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 15. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 16. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 17. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 18. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 19. UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 20. UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 21. UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 22. France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 23. France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 24. France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 25. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 26. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 27. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 28. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 29. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 30. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 31. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 32. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 33. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 34. China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 35. China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 36. China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 37. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 38. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 39. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 40. India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 41. India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 42. India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 43. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 44. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 45. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 46. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 47. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 48. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 49. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 50. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 51. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 52. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 53. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 54. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 55. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 56. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 57. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 58. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 59. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 60. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 61. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 62. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 63. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 64. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 65. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 66. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 67. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 68. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 69. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 70. Organic Developments Done by the Companies
  • Table 71. Inorganic Developments Done by the Companies
  • Table 72. Glossary of Terms, Cell Line Development Market

List Of Figures

  • Figure 1. Cell Line Development Market Segmentation
  • Figure 2. Cell Line Development Market Segmentation, By Region
  • Figure 3. Global Cell Line Development Market Overview
  • Figure 4. Recombinant Cell Line Segment Held Largest Share of Type Segment in Cell Line Development Market
  • Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Cell Line Development Market, By Geography (US$ Mn)
  • Figure 7. Global Cell Line Development Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Cell Line Development Market, Industry Landscape
  • Figure 9. Cell Line Development Market in North America: PEST Analysis
  • Figure 10. Cell Line Development Market in Europe: PEST Analysis
  • Figure 11. Cell line development Market in APAC: PEST Analysis
  • Figure 12. Cell Line Development Market MEA: PEST Analysis
  • Figure 13. Cell Line Development Market - South and Central America PEST Analysis
  • Figure 14. Most Prevalent Forms of Cancers Globally, 2018
  • Figure 15. Cell Line Development Market Impact Analysis of Driver and Restraints
  • Figure 16. Global Cell Line Development Market - Revenue Forecast and Analysis - 2019- 2027
  • Figure 17. Global Cell Line Development Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 18. Market Positioning of Key Players in Global Cell line development Market
  • Figure 19. Global Cell Line Development Market, Type, 2019 & 2027 (% Share)
  • Figure 20. Global Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 21. Global Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 22. Global Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 23. Global Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 24. Global Cell Line Development Market, By Product, 2019 & 2027 (% Share)
  • Figure 25. Global Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 26. Global Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 27. Global Cell Line Development Market Share by Application 2019 & 2027 (%)
  • Figure 28. Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 29. Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 30. Global Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 31. North America Cell Line Development Market Overview, By Country - 2019 (US$ Mn)
  • Figure 32. North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 33. North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 34. US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 35. Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 36. Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 37. Europe Cell Line Development Market Revenue, By Country, 2019 (US$ Mn)
  • Figure 38. Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 39. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 40. Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 41. UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 42. France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 43. Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 44. Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 45. APAC Cell Line Development Market Revenue Overview, By Country (2019) (US$ Mn)
  • Figure 46. APAC Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 47. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 48. China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 49. Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 50. India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 51. South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 52. Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 53. MEA Cell Line Development Market, Revenue Overview, By Country, 2019 (US$ Mn)
  • Figure 54. MEA Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 55. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 56. UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 57. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 58. South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 59. South and Central America Cell Line Development Market, Revenue Overview, By Country, 2019 (US$ Mn)
  • Figure 60. South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 61. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 62. Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 63. Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 64. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 65. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 66. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 67. Impact Of COVID-19 Pandemic in Rest of the World Market
  • Figure 68. Growth Strategies Done by the Companies in The Market, (%)
目次
Product Code: TIPHE100001196

Title:
Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography.

The cell line development market was valued at US$ 4,160.42 million in 2019 and is projected to reach US$ 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027.

Increasing adoption of regenerative medicines, rising prevalence of cancer around the globe, and increasing investments in R&D by pharmaceutical and biotechnology companies are among the major factors fueling the growth of this market. Moreover, consistent research in drug discovery is expected to foster the market growth during the forecast period. However, the risk of cell line contamination hinders the growth of the cell line development market. Additionally, the APAC countries are facing challenges due to the rising prevalence of COVID-19. As per the data of Worldometer, the total number of COVID-19 cases in the region was 7,413,721 on September 2, 2020. In addition to the adverse effects of pandemic, uncertainty around economic recovery has affected the pharmaceutical industry in the region. Major pharmaceutical companies in the region are engaged in the development of the potential COVID-19 vaccine, and research projects on other therapeutics have been put on hold; this is expected to hinder the growth of the cell line development market in APAC.

The cell line is an established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from different cells. Cell lines enable stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.

The global cell line development market is segmented by type, product, and application. Based on type, the market is segmented into primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019; however, the hybridomas segment is anticipated to register the highest CAGR during the forecast period. Based on product, the cell line development market is segmented into equipment, and media and reagent. The media and reagent segment held a larger share of the market in 2019; and is anticipated to register a higher CAGR during the forecast period. Based on application, the cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The bioproduction segment held the largest share of the market in 2019; however, the market for the drug discovery segment is estimated to grow at the fastest CAGR during 2020-2027.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and American Academy of Ophthalmology are a few of the primary and secondary sources associated with this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global cell line development market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cell Line Development Market - By Type
    • 1.3.2 Global Cell Line Development Market - By Product
    • 1.3.3 Global Cell Line Development Market - By Application
    • 1.3.4 Global Cell Line Development Market - By Geography

2. Cell Line Development Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Cell Line Development - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Cell Line Development Market in North America: PEST Analysis
    • 4.2.2 Cell Line Development Market in Europe: PEST Analysis
    • 4.2.3 Cell line development Market in APAC: PEST Analysis
    • 4.2.4 Cell Line Development Market in MEA: PEST Analysis
    • 4.2.5 Cell Line Development Market - South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Global Cell Line Development Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Adoption of Regenerative Medicines
    • 5.1.2 Rising Prevalence of Cancer
    • 5.1.3 Growing Investment in R&D by Pharmaceutical and Biotechnology Companies
  • 5.2 Key Restraints
    • 5.2.1 Risk Associated with Cell Line Contamination
  • 5.3 Key Opportunity
    • 5.3.1 Middle Income Countries Creating Development Opportunities
  • 5.4 Future Trend
    • 5.4.1 Consistent Research in Drug Discovery Activities
  • 5.5 Impact Analysis

6. Cell Line Development Market - Global Analysis

  • 6.1 Global Cell Line Development Market Revenue Forecast and Analysis
  • 6.2 Global Cell Line Development Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players
    • 6.3.1 Merck KGaA
    • 6.3.2 Thermo Fisher Scientific Inc.

7. Cell Line Development Market - Revenue and Forecasts to 2027 - Type

  • 7.1 Overview
  • 7.2 Global Cell Line Development Market, by Type, 2019 & 2027 (% Share)
  • 7.3 Primary Cell Line
    • 7.3.1 Overview
    • 7.3.2 Global Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Hybridomas
    • 7.4.1 Overview
    • 7.4.2 Global Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Continuous Cell Lines
    • 7.5.1 Overview
    • 7.5.2 Global Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Recombinant Cell Line
    • 7.6.1 Overview
    • 7.6.2 Global Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)

8. Cell Line Development Market Analysis and Forecasts to 2027 - Product

  • 8.1 Overview
  • 8.2 Global Cell Line Development Market, by Product, 2019 & 2027 (% Share)
  • 8.3 Equipment
    • 8.3.1 Overview
    • 8.3.2 Global Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Media and Reagent
    • 8.4.1 Overview
    • 8.4.2 Global Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)

9. Cell Line Development Market Analysis and Forecasts to 2027 - Application

  • 9.1 Overview
  • 9.2 Global Cell Line Development Market Share by Application 2019 & 2027 (%)
  • 9.3 Drug Discovery
    • 9.3.1 Overview
    • 9.3.2 Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Bioproduction
    • 9.4.1 Overview
    • 9.4.2 Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Tissue Engineering
    • 9.5.1 Overview
    • 9.5.2 Global Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)

10. Cell Line Development Market Revenue and Forecast to 2027 - Geographical Analysis

  • 10.1 North America Cell Line Development Market, Revenue and Forecast to2027
    • 10.1.1 Overview
    • 10.1.2 North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.1.3 North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.1.4 North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.1.5 North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.6 North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.1.7 US
      • 10.1.7.1 US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.7.2 US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.7.3 US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.7.4 US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.8 Canada
      • 10.1.8.1 Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.8.2 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.8.3 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.8.4 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.9 Mexico
      • 10.1.9.1 Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.9.2 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.9.3 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.9.4 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • 10.2 Europe Cell Line Development Market Revenue and Forecast to 2027
    • 10.2.1 Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.2.2 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.2.3 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.2.4 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.2.5 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.2.6 Germany
      • 10.2.6.1 Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.2.6.2 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.2.6.3 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.2.6.4 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.2.7 UK
      • 10.2.7.1 UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.2.7.2 UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.2.7.3 UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.2.7.4 UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.2.8 France
      • 10.2.8.1 France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.2.8.2 France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.2.8.3 France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.2.8.4 France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.2.9 Spain
      • 10.2.9.1 Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.2.9.2 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.2.9.3 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.2.9.4 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.2.10 Italy
      • 10.2.10.1 Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.2.10.2 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.2.10.3 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.2.10.4 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • 10.3 APAC Cell Line Development Market, Revenue and Forecast to 2027
    • 10.3.1 Overview
    • 10.3.2 APAC Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.3.3 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.3.4 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.3.5 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.3.6 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.3.7 China
      • 10.3.7.1 China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.3.7.2 China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.3.7.3 China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.3.7.4 China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.3.8 Japan
      • 10.3.8.1 Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.3.8.2 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.3.8.3 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.3.8.4 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.3.9 India
      • 10.3.9.1 India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.3.9.2 India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.3.9.3 India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.3.9.4 India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.3.10 South Korea
      • 10.3.10.1 South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.3.10.2 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.3.10.3 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.3.10.4 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.3.11 Australia
      • 10.3.11.1 Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.3.11.2 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.3.11.3 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.3.11.4 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • 10.4 MEA Cell Line Development Market, Revenue and Forecast to 2027
    • 10.4.1 Overview
    • 10.4.2 MEA Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.4.3 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.4.4 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.4.5 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.4.6 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.4.7 UAE
      • 10.4.7.1 UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.4.7.2 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.4.7.3 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.4.7.4 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.4.8 Saudi Arabia
      • 10.4.8.1 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.4.8.2 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.4.8.3 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.4.8.4 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.4.9 South Africa
      • 10.4.9.1 South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.4.9.2 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.4.9.3 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.4.9.4 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • 10.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027
    • 10.5.1 Overview
    • 10.5.2 South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.5.3 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.5.4 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.5.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.5.6 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.5.7 Brazil
      • 10.5.7.1 Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.5.7.2 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.5.7.3 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.5.7.4 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.5.8 Argentina
      • 10.5.8.1 Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.5.8.2 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.5.8.3 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.5.8.4 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

11. Impact Of COVID-19 Pandemic on Global Cell Line Development Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Cell Line Development Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in The Market, (%)
  • 12.3 Organic Developments Done by The Companies in the Market
  • 12.4 Inorganic Developments Done by The Companies in the Market

13. Cell Line Development Market- Key Company Profiles

  • 13.1 Merck KGaA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Financial Overview
    • 13.1.4 Product Portfolio
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific, Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Financial Information
    • 13.2.4 Product /Services Portfolio
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sartorius AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Financial Overview
    • 13.3.4 Product Portfolio
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 SELEXIS
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Financial Overview
    • 13.4.4 Product/Service Portfolio
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 BioFactura, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Financial Overview
    • 13.5.4 Product Portfolio
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 WuXi AppTec
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Financial Overview
    • 13.6.4 Service Portfolio
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 LakePharma, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Financial Overview
    • 13.7.4 Product Portfolio
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 General Electric
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Financial Overview
    • 13.8.4 Product Portfolio
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Lonza
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Financial Information
    • 13.9.4 Product Portfolio
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Corning Incorporated
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Overview
    • 13.10.4 Product Portfolio
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.